drugset

drugset / Trial / NCT00525382

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

NCT00525382 ↗

Phase 3 Completed 134 enrolled UCB Pharma

RandomizedParallel-groupSingle-blindTreatment

Summary

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria.

Timeline

Start: 2003-08
Primary completion: 2004-03
Completion: 2004-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levocetirizine	Unknown	5 mg	Oral

Indications